This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here.

FSA to ban marketing of traded life investments to retail investors

  • Print
  • Comments (20)

The FSA has warned traded life policy investments are high risk, toxic products which should not be promoted to UK retail investors.

The regulator says it aims to ban TLPIs from being marketed to UK retail investors in a guidance consultation paper published this morning.

TLPIs are known as ‘death bonds’ because investors are putting their money into a pooled investment or fund which invests in US life insurance policies. Investors are essentially betting on when a particular set of US citizens will die and if these people live longer than expected then the investment may not function as expected.

Life settlement policies were the underlying investment behind Keydata products. The collapse of Keydata triggered an industry interim levy of £326m, with advisers paying £93m and fund managers paying £233m.

The FSA says evidence from its work to date has found significant problems with the way in which TLPIs are designed, marketed and sold to UK retail investors.  Many of these products have failed, causing loss for UK retail investors.  

FSA managing director Margaret Cole says: “The failure of these products in the past has led to significant consumer detriment and we fear new investors will suffer unless we take the necessary steps now to prevent their sale and distribution.

“We are issuing a strong warning to the industry not to market these products to UK retail investors. Ultimately we aim to ban TLPIs from being marketed to UK retail investors, and we intend to consult on this next year to help erase the risks they pose.”

The FSA says firms should consider the significant risks of TLPIs and be aware that they should not be promoted to UK retail investors.

Firms should carry out extensive research into the products and be able to justify recommending them in the “unlikely event” they think the products are suitable.

Firms should also be aware of the underlying assets involved, and should not recommend products they do not understand.

The FSA has found that some TLPIs lack sufficient liquidity to meet ongoing costs if the people whose life policies they have bought live longer than expected.

It says if the TLPI provider needs to sell assets to raise funds, they may find it difficult to sell the underlying policies at a reasonable price, due to the small market and its specialised nature, and this may lead to losses for investors.

If the firm needs to sell the assets and cannot find a buyer quickly, this could also mean that investors find their money locked into a TLPI for longer than expected.

Finally, if the underlying assets of the TLPI are based offshore there is also an exchange rate risk, both in terms of the costs of meeting ongoing premiums and the final payout for the underlying insurance contracts.

Investors may have limited or no recourse to the Financial Services Compensation Scheme and Financial Ombudsman Service as many TLPIs are located offshore.

The guidance consultation closes on 23 January, 2012.

EEA Fund Management marketing director Peter Winders says: “We agree with the FSA’s desire to ensure that investors understand product risks and are placed into suitable investments. That’s why our investment minimum on the EEA life settlements fund is £25,000 and why we make clear this is for sophisticated investors under advice.”

  • Print
  • Comments (20)

Daily Email Updates
If you enjoyed this article, sign up to receive the latest news and analysis from Money Marketing.

Money Marketing Awards 2015
Put your firm forward as the leading practitioner in your field. Adviser and Advertising categories are open to entries - Enter Now.

Readers' comments (20)

  • It was known for a long while that TLPI,s in America were a dodgy investment. What was not known that these were behind Key Data strategy.

    Unsuitable or offensive? Report this comment

  • Money Marketing 24 Feb 2010 - 'The FSA says it has "significant concerns" about the way in which life settlement policies are being brought to market and it has uncovered "major flaws" in the marketing of the products...'

    21 months later...

    Unsuitable or offensive? Report this comment

  • Typical FSA, Horses & stable doors come to mind

    Unsuitable or offensive? Report this comment

  • It seems a bit late for the FSA to issue this warning! I think that we are all fully aware of the risk now. Perhaps the FSA should have looked into Keydata at the time they were marketting this product and assessed the risk then rather than now that Keydata has gone belly up! Keydata were after all authorised and regulated by the FSA and somehow managed to market these policies into stocks and shares ISA's which has baffled me.It seems that the FSA will not accept their part in the Keydata affair and are blaming IFA's and Building Society's for recommending them and issue this warning after the boat has sunk!

    Unsuitable or offensive? Report this comment

  • Oddly enough I agree with Margaret Coles.

    Bit on the tardy side of regulatory action. But hey who is surprised - thematic review anyone?

    Our own compliance services provider researched a particular Life Settlements fund and stated, lo & behold each indivdual investor should have a holding in this fund. Diversification you see.

    I am of the opinion that they are not all rogue but I don't like the lack of FSCS coverage and concerns over liquidity.

    Funnily enough had an email showing a particular funds escalating performance this morning.

    Unsuitable or offensive? Report this comment

  • But wasn't the system back-tested by WXYZ accountants, one of the biggest in the world? How can the scheme possibly fail?

    Ha Ha.

    Unsuitable or offensive? Report this comment

  • Point, fine, ban.

    Is this what regulation is all about? Allow everything to go sour and then trip over it?

    What has regulation done for society?


    And that doesn't stand for Securities and Futures Authority.

    Unsuitable or offensive? Report this comment

  • This is absurd.

    One event that may lead to failures in these funds is for a scare story to circulate that could lead to a liquidity issue.
    Would the FSA really try and justify its actions by telling us they told us so because fo failures arising solely from their hysterical overreaction.

    If this happens with Life Settlements due to this sort of ignorance at the FSA do we as advisers sue them for any losses sustained by clients?

    Also, what constitutes "marketing"? We have advised clients to invest in these funds, but we have not marketed them to anyone.

    Ian Coley
    Medical Investment Services

    Unsuitable or offensive? Report this comment

  • I cannot see anything wrong with the principle that if a company owns a large number of life policies then an actuarial calculation should be able to establish how much revenue the fund could expect given the statistical probabilty that so many people will die in a certain number of years. We will never know what went wrong at Keydata until there is an enquiry, finding out who knew what, when, and what did they do about it. What were advisers supposed to tell their clients when they advised on these products offered by a regulated firm covered with the FSCS? Oh, by the way, here's a brochure. Don't take any notice of it because its a pack of lies?

    Unsuitable or offensive? Report this comment

  • Ridiculous approach by FSA

    Unsuitable or offensive? Report this comment

View results 10 per page | 20 per page

Have your sayEdit my profile/screen name

You must sign in to make a comment

Fund Data

Editor's Pick


Do you see the value in adviser trade bodies?

Job of the week

Latest jobs

View all jobs

Most recent comments

View more comments